ovel approaches in IVF.
Completed
- Registration Number
- NL-OMON23935
- Lead Sponsor
- Department of Reproductive Medicine, University Medical Center, Utrecht, The Netherlands.
- Brief Summary
1. Lancet. 2007 Mar 3;369(9563):743-9.<br> <br><br> 2. Hum Reprod. 2008 Feb;23(2):316-23. Epub 2007 Nov 22.<br> <br><br> 3. Ned Tijdschr Geneeskd. 2008 Apr 5;152(14):809-16.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 400
Inclusion Criteria
Patients with an indication for IVF or IVF/ Intracytoplasmic Sperm Injection (ICSI) based on tubal, male or unexplained infertility were recruited. Patients under < 38 years with a normal menstrual cycle (cycle length between period 25-35 days) and without severe obesity or underweight (body mass index (BMI) 18-28 kg/m2) were eligible for the study.
Exclusion Criteria
N/A
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome parameters chosen for this study were: <br /><br>1. Pregnancy within one year of treatment after randomization leading to term (¡Ý 37 weeks gestation) live birth;<br /><br>2. Total costs per couple and child up to 6 weeks after expected delivery, and (3) patient discomfort/distress during IVF treatment. <br />
- Secondary Outcome Measures
Name Time Method